May 4, 2021 Experience Vaccitech $110.5 million IPO We advised the underwriters on the IPO and Nasdaq listing
May 3, 2021 Experience Aveanna $458.8 million IPO We advised the underwriters on the IPO and Nasdaq listing
May 3, 2021 Experience Privia Health $525.8 million IPO We advised Privia Health on its IPO and Nasdaq listing
May 3, 2021 Experience Roivant Sciences combination with Montes Archimedes Acquisition We are advising Roivant Sciences on its combination with a SPAC
April 26, 2021 Experience NeuroPace $102 million IPO We advised the underwriters in connection with the IPO and Nasdaq listing
April 20, 2021 Experience Akoya Biosciences $151.3 million IPO We advised the underwriters on the IPO and Nasdaq listing
April 20, 2021 Experience Recursion Pharmaceuticals $500 million IPO We advised the underwriters on the IPO and Nasdaq listing
March 30, 2021 Experience LAVA Therapeutics $100.5 million IPO We advised the underwriters on the IPO and Nasdaq listing
March 23, 2021 Experience Connect Biopharma $219.9 million IPO We advised the underwriters on the IPO and Nasdaq listing
March 16, 2021 Experience Prometheus Biosciences $218.5 million IPO We advised the underwriters on the IPO and Nasdaq listing